Wendy S. Arnold
Keine laufenden Positionen mehr
Vermögen: 24 817 $ am 30.04.2024
Profil
Wendy S.
Arnold worked as the Director of Human Resources at Avila Therapeutics, Inc. from 2011 to 2014.
She then worked as the Head of Human Resources at Moderna, Inc. from 2014 to 2017.
In 2018, she became the Senior Vice President of Human Resources at Kaleido Biosciences, Inc. until 2020.
From 2020 to 2023, she served as the Chief People Officer at Frequency Therapeutics, Inc. Ms. Arnold received an undergraduate degree from Colorado State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
0,00% | 26.01.2023 | 424 ( 0,00% ) | 24 817 $ | 30.04.2024 |
Ehemalige bekannte Positionen von Wendy S. Arnold
| Unternehmen | Position | Ende |
|---|---|---|
| KORRO BIO, INC. | Personalreferent | 31.03.2023 |
| KALEIDO BIOSCIENCES, INC. | Personalreferent | 31.01.2020 |
| MODERNA, INC. | Personalreferent | 01.12.2017 |
Avila Therapeutics, Inc.
 Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avila Therapeutics, Inc. researches and develops covalent drugs. The company was founded in 2007 and is headquartered in Summit, NJ. | Personalreferent | 01.01.2014 |
Ausbildung von Wendy S. Arnold
| Colorado State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| KALEIDO BIOSCIENCES, INC. | Health Technology |
| MODERNA, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Avila Therapeutics, Inc.
Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Avila Therapeutics, Inc. researches and develops covalent drugs. The company was founded in 2007 and is headquartered in Summit, NJ. | Health Technology |
Frequency Therapeutics, Inc.
 Frequency Therapeutics, Inc. BiotechnologyHealth Technology Frequency Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the business of developing therapeutics to activate a person's innate regenerative potential to restore function. The firm is also involved in creating and commercializing therapeutics to potentially transform the lives of individuals by repairing or reversing damage done to cells, tissue, and organs. The company was founded by Robert S. Langer, David L. Lucchino, Christopher R. Loosey, and Will J. McLean on November 13, 2014 and is headquartered in Lexington, MA. | Health Technology |